Regulus Therapeutics makes appointment
This article was originally published in Scrip
Executive Summary
Regulus Therapeutics, a California-based company developing microRNA therapeutics, has appointed Dr Zachary Zimmerman director of business development. Dr Zimmerman previously worked in the business development group at Alnylam Pharmaceuticals, where he was responsible for government affairs, external alliances and developing new business partnerships.